Article info
Mitochondrial genetics
De novo mtDNA point mutations are common and have a low recurrence risk
- Correspondence to Suzanne C E H Sallevelt, Department of Clinical Genetics, Maastricht University Medical Centre (MUMC), P. Debeyelaan 25, P.O. Box 5800, Maastricht 6202 AZ, The Netherlands; suzanne.sallevelt{at}mumc.nl
Citation
De novo mtDNA point mutations are common and have a low recurrence risk
Publication history
- Received March 1, 2016
- Revised June 2, 2016
- Accepted June 9, 2016
- First published July 22, 2016.
Online issue publication
January 20, 2017
Article Versions
- Previous version (22 July 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/